Clinical Trials Logo
  1. Home
  2. Bipolar Disorder
  3. NCT00927420
  4. Details
NCT00927420 Clinical Trial

Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

Bipolar Disorder Clinical Trial

Official title:
Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00927420
Other study ID # NIS-NES-DUM-2009/1
Secondary ID
Status Completed
Phase N/A
First received June 23, 2009
Last updated October 29, 2009
Start date July 2009
Est. completion date October 2009

Study information
Verified date October 2009
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Spain: Comité Ético de Investigación Clínica
Study type Observational

Clinical Trial Summary

The purpose of this study is to estimate adherence to treatment in bipolar patients, to characterize patients based on adherence degree and to describe the variables linked to poor adherence to treatment in real-life practice.

Recruitment information / eligibility
Status Completed
Enrollment 300
Est. completion date October 2009
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients diagnosed with bipolar disorder I or II DSM-IV

- Patients treated with at least one oral antipsychotic

- Subjects able to read and write

Exclusion Criteria:

- Patients participating in clinical trials

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Locations
Country Name City State
Spain Research Site Alicante
Spain Research Site Almeria
Spain Research Site Badajoz
Spain Research Site Barcelona
Spain Research Site Calahorra La Rioja
Spain Research Site Cordoba
Spain Research Site Elche
Spain Research Site La Laguna Tenerife
Spain Research Site Langreo Asturias
Spain Research Site Las Palmas Gran Canarias
Spain Research Site Leon
Spain Research Site Lerida
Spain Research Site Madrid
Spain Research Site Malaga
Spain Research Site Murcia
Spain Research Site Orense
Spain Research Site Palma de Mallorca
Spain Research Site Salamanca
Spain Research Site Sevilla
Spain Research Site Toledo
Spain Research Site Valencia
Spain Research Site Valladolid
Spain Research Site Vitoria
Spain Research Site Zaragoza

Sponsors (1)
Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Morisky-Green Scale Once, at the visit moment No
Primary Drug Attitude Inventory Scale (DAI-10) Once, at the visit moment No
Secondary Clinical Global Impressions for Bipolar illness-modified (CGI-BP-M) Once, at the visit moment No
Secondary Functioning Assessment Short Test (FAST) Once, at the visit moment No
See also
  Status Clinical Trial Phase
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT02855762 - Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder N/A
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Completed NCT02513654 - Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects Phase 1
Recruiting NCT06313918 - Exercise Therapy in Mental Disorders-study N/A
Completed NCT02304432 - Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine Early Phase 1
Recruiting NCT06197048 - Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder N/A
Completed NCT03497663 - VIA Family - Family Based Early Intervention Versus Treatment as Usual N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT02212041 - Electronic Cigarettes in Smokers With Mental Illness N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Active, not recruiting NCT03641300 - Efficacy of Convulsive Therapies for Bipolar Depression N/A
Not yet recruiting NCT04432116 - Time and Virtual Reality in Schizophrenia and Bipolar Disorder N/A
Completed NCT02970721 - Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Terminated NCT02893371 - Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Terminated NCT02909504 - Gao NARASD Lithium Study Phase 4
Recruiting NCT02481245 - BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study Phase 2
Recruiting NCT03088657 - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study